Chronic heart failure
351 results
1 - 100
Chronic heart failure - Essentials
- Drug choice and use in HF
- In general
- Treatment of AF in HF
- Pacemaker therapy
- Treatment of HF in the elderly
- Management of worsening HF or treatment-resistant HF
- Patient education and self-care
- Follow-up
- End-of-life treatment
- References
- Precipitating and exacerbating factors of HF
- Diagnosis
- Symptoms
- Clinical findings
- Additional investigations
- Indication for specialist consultation and investigations
- Treatment of systolic HF
- Diastolic HF
Ivabradine as adjuvant treatment for chronic heart failure- Hawthorn extract for treating chronic heart failure
Aliskiren not beneficial for chronic heart failure (ATMOSPHERE)- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
- Pharmacological interventions for heart failure in people with chronic kidney disease
- Ivabradine as adjuvant treatment for chronic heart failure
- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
- Structured telephone support or telemonitoring for chronic heart failure
- Erythropoiesis‐stimulating agents for anaemia in chronic heart failure patients
- Drugs for chronic heart failure with preserved ejection fraction
- IV iron improves symptoms in chronic heart failure patients with iron deficiency
- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
- Finerenone decreases hospitalization for heart failure in patients with type 2 diabetes and chronic kidney disease (NNT = 189/year)
- Phosphodiesterase III inhibitors for heart failure
- Increased pulmonary blood pressure: pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
- Diuretics for heart failure: Cochrane systematic review
- Acute heart failure and pulmonary oedema
- Sertraline ineffective for depression associated with heart failure
- Nitrates for acute heart failure syndromes
- New "-flozin" type 2 diabetes treatments improve outcomes in patients with heart failure, with or without diabetes
- BNP-guided therapy decreases heart failure mortality (BATTLESCARRED)
- Interpreting BNP in patients with a history of HF
- Point-of-care BNP testing may be helpful to rule out heart failure
- Improved decongestion with the addition of acetazolamide to intravenous loop diuretics for acute heart failure
- Antioxidants for adults with chronic kidney disease
- Exercise stress test
- Intravenous iron therapy improves quality of life in iron-deficient adults with heart failure
- Guideline for the management of heart failure: early prevention for patients at risk, quadruple therapy for those with symptoms
- Chronic coronary syndrome (coronary heart disease)
- LCZ696 (sacubitril/valsartan) for patients with heart failure
- Prolonged cough in adults
- Sotagliflozin reduces hospitalizations and urgent visits for heart failure, but has no mortality benefit (SCORED)
- Carvedilol not beneficial for children and adolescents with heart failure